In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST

• المؤلفون الرئيسيون: Mahnaz Fatahinia (مؤلف), Marzieh Halvaeizadeh (مؤلف), Ali Zarei Mahmoudabadi (مؤلف), Elham AboualiGalehdari (مؤلف), Neda Kiasat (مؤلف)
• التنسيق: كتاب
• منشور في: Mazandaran University of Medical Sciences, 2020-06-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

<strong>Background and Purpose:</strong> Candida glabrata is the second cause of candidiasis. The mortality rate of C. glabrata infections is about 40%; accordingly, it may be life threatening, especially in immunocompromised hosts. Regarding this, the current study was conducted to eval...